The simplicity of enzyme-linked immunosorbent assays (ELISAs) has made them a popular assay for detecting and quantifying proteins, antibodies, peptides, and more.
However, traditional ELISAs suffer from low sensitivity, meaning some biomarkers are difficult to detect, and others are completely undetectable using this method.
Join this webinar to discover how switching from ELISAs to an ultrasensitive biomarker detection platform increases assay sensitivity by up to 1,000-fold, allowing you to detect the previously undetectable.
In this webinar, you will discover:
For Research Use Only. Not For Use In Diagnostic Procedures.
Senior Scientific Sales Manager
Craig was a Field Application Scientist with the Immunoassay Platform Solutions team for almost 15 years. Prior to coming to MilliporeSigma, he was a scientist with multiple biopharma companies where he participated in every stage of the drug discovery process, including analytical method development and assay validation. Craig is currently Senior Scientific Sales Manager with the Global Strategic Accounts Team at MilliporeSigma.
Session 1:presented November 16, 2021
To continue reading please sign in or create an account.Don't Have An Account?